compared to the last quarter of last year. However, most of these accounts receivable are not overdue. Other receivables increased Baht 47.83 million mainly from deposit paid for mold of new model in

same period of the previous year. The net loss was Baht 22.57 million, representing an increase of Baht 22.75 million. Up to 100.80 percent. The causes are as follows. 1. Revenue from sales and services

Company and its subsidiary for Quarter 3 of 2019 ending on 30 September 2019 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical

of 14.81 million baht, reversing from a net profit of 1.89 million baht reported for the same period of last year and representing a bigger loss of 16.70 million baht. The details are as follows

1,342.54 96.75% 729.94 97.88% 83.92% Profit from operating activities 45.11 3.25% 15.84 2.12% 184.79% Finance cost 2.89 0.21% 0.90 0.12% 221.11% Profit before income tax expenses 42.23 3.04% 14.94 2.00

subsidiary for Quarter 1 of 2020 ending on 31 March 2020 as follows; Statements of Comprehensive Income Revenue from medical treatment The Company generated the revenue from medical treatment for the 1st

Revenues from sales Revenues from sales 56.46 72.01 (15.55 ) (0.22 ) Other income 1.66 1.96 (0.30 ) (0.15 ) Total Revenue 58.12 73.97 (15.85 ) (0.21 ) Expenses Cost of sales 37.80 64.34 (26.54 ) (0.41

the previous year, the net loss was 91.97 million baht, the company had a net loss, a decrease from the same period of last year equal to 56.58 million baht. The company would like to clarify the

loss of 58.59 million baht, a net loss decreased from the same period of the previous year equal to 18.78 million baht or 32.05 percent; The company has an important change to clarify as follows. 1

Baht 81.76 million, whereas net profit of Baht 161.84 million in the same period of prior year, mainly results from; 1. Revenue from sales increased by Baht 103.76 million because the Company has Revenue